1.Predictive factors for malignancy in undiagnosed isolated small bowel strictures.
Ujjwal SONIKA ; Sujeet SAHA ; Saurabh KEDIA ; Nihar Ranjan DASH ; Sujoy PAL ; Prasenjit DAS ; Vineet AHUJA ; Peush SAHNI
Intestinal Research 2017;15(4):518-523
BACKGROUND/AIMS: Patients with small bowel strictures have varied etiologies, including malignancy. Little data are available on the demographic profiles and etiologies of small bowel strictures in patients who undergo surgery because of intestinal obstruction but do not have a definitive pre-operative diagnosis. METHODS: Retrospective data were analyzed for all patients operated between January 2000 and October 2014 for small bowel strictures without mass lesions and a definite diagnosis after imaging and endoscopic examinations. Demographic parameters, imaging, endoscopic, and histological data were extracted from the medical records. Univariate and multivariate analyses were conducted to identify factors that could differentiate between intestinal tuberculosis (ITB) and Crohn's disease (CD) and between malignant and benign strictures. RESULTS: Of the 7,425 reviewed medical records, 89 met the inclusion criteria. The most common site of strictures was the proximal small intestine (41.5%). The most common histological diagnoses in patients with small bowel strictures were ITB (26.9%), CD (23.5%), non-specific strictures (20.2%), malignancy (15.5%), ischemia (10.1%), and other complications (3.4%). Patients with malignant strictures were older than patients with benign etiologies (47.6±15.9 years vs. 37.4±16.4 years, P=0.03) and age >50 years had a specificity for malignant etiology of 80%. Only 7.1% of the patients with malignant strictures had more than 1 stricture and 64% had proximally located strictures. Diarrhea was the only factor that predicted the diagnosis of CD 6.5 (95% confidence interval, 1.10–38.25; P=0.038) compared with the diagnosis of ITB. CONCLUSIONS: Malignancy was the cause of small bowel strictures in approximately 16% patients, especially among older patients with a single stricture in the proximal location. Empirical therapy should be avoided and the threshold for surgical resection is low in these patients.
Constriction, Pathologic*
;
Crohn Disease
;
Diagnosis
;
Diarrhea
;
Humans
;
Intestinal Obstruction
;
Intestine, Small
;
Ischemia
;
Medical Records
;
Multivariate Analysis
;
Retrospective Studies
;
Sensitivity and Specificity
;
Tuberculosis
2.Malignant Schwannoma of the Esophagus: A Rare Case Report.
Biswajit MISHRA ; Kumble Seetharama MADHUSUDHAN ; Ragini KILAMBI ; Prasenjit DAS ; Sujoy PAL ; Deep Narayan SRIVASTAVA
The Korean Journal of Thoracic and Cardiovascular Surgery 2016;49(1):63-66
Neurogenic tumors are the most prevalent tumors of the mediastinum, and schwannomas are the most common type of neurogenic tumor. Primary neurogenic neoplasm of the esophagus is uncommon and malignant schwannoma of the esophagus is extremely rare. We report a case of a 27-year-old female presenting with dysphagia and palpitations who was found to have a lobulated tumor in the mediastinum that was compressing the esophageal lumen. The tumor was successfully treated surgically without recurrence. The final diagnosis, on histopathological examination of the specimen, was malignant schwannoma.
Adult
;
Deglutition Disorders
;
Diagnosis
;
Esophagogastric Junction
;
Esophagus*
;
Female
;
Humans
;
Mediastinum
;
Neurilemmoma*
;
Recurrence
;
Tomography, X-Ray Computed
3.Topographic, histological and molecular study of aberrant crypt foci identified in human colon in different clinical groups
Shouriyo GHOSH ; Brijnandan GUPTA ; Pavan VERMA ; Sreenivas VISHNUBATHLA ; Sujoy PAL ; Nihar R DASH ; Siddhartha Datta GUPTA ; Prasenjit DAS
Intestinal Research 2018;16(1):116-125
BACKGROUND/AIMS: Aberrant crypt foci (ACF) are early microscopic lesions of the colonic mucosa, which can be detected by magnified chromoendoscopy. Herein, we have investigated whether ACF identified in different clinical groups can be differentiated based on their characteristics. METHODS: Macroscopically unremarkable mucosal flaps were collected from 270 fresh colectomies and divided into 3 clinical groups: colorectal carcinoma (group A), disease controls having known pre-neoplastic potential (group Bc), and disease controls without risk of carcinoma development (group Bn). Topographic and histologic analysis, immunohistochemistry, and molecular studies (high-resolution melt curve analysis, real-time polymerase chain reaction, and Sanger sequencing) were conducted for certain neoplasia-associated markers. RESULTS: ACF were seen in 107 cases, out of which 72 were left colonic ACF and 35 right colonic ACF (67.2% vs. 32.7%, P=0.02). The overall density of left colonic ACF was 0.97/cm, which was greater than the right colonic ACF density of 0.81/cm. Hypercrinia was present in 41 out of 72 left colonic ACF and in 14 out of 35 right colonic ACF (P=0.01). Immunohistochemical expression of p53 was also greater in left colonic ACF than in right colonic ACF (60.5% vs. 38.2%, P=0.03). However, ACF identified among the 3 clinical groups did not show any distinguishing topographic, histological, or genetic changes. CONCLUSIONS: Left colonic ACF appear to be high-risk based on their morphological and prototypic tumor marker signature. ACF identified in different clinical groups do not show significant genotypic or topographic differences. Further detailed genetic studies are required to elucidate them further.
Aberrant Crypt Foci
;
Colectomy
;
Colon
;
Colorectal Neoplasms
;
Humans
;
Immunohistochemistry
;
Mucous Membrane
;
Real-Time Polymerase Chain Reaction